ATOSSA THERAPEUTICS

Company snapshot

Developing precision therapeutics for patients with chronic inflammatory diseases incorporating artificial intelligence and machine learning algorithms

• 10 active pipeline program(s) linked via ClinicalTrials.gov.
• 8 US patent(s) indexed to this assignee profile.
• 10 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for ATOSSA THERAPEUTICS. Not investment advice.

• Peer + 0 momentum

  Eli Lilly and

  TA overlap score 32.4

• Peer + 0 momentum

  PUMA BIOTECHNOLOGY

  TA overlap score 28

• Peer + 0 momentum

  Sun Yat-sen Memorial

  TA overlap score 21.4

Recent activity

Latest pipeline, patent, and corporate events for ATOSSA THERAPEUTICS.

1. Jun 8, 2026 Clinical update

   (Z)-endoxifen — Phase 2

2. Jun 8, 2026 Clinical update

   Topical endoxifen — Phase 2

3. Jun 5, 2026 Clinical update

   Provox Vega voice prosthesis 22.5 Fr — Phase 2

4. May 23, 2026 Clinical update

   ForeCYTE Breast Aspirator — Phase 3

5. May 23, 2026 Clinical update

   ASCAPE-based follow-up strategy — Phase 2

View all clinical trial activity →

• What is ATOSSA THERAPEUTICS?

  Athos Therapeutics is a pharma organization headquartered in Torrance, USA. It trades on NYSE under ticker ATOS. Primary therapeutic focus areas include Total Laryngectomy, Breast Cancer, Breast Cancer, Preneoplastic Conditions, BRCA, Female Breast Carcinoma, Mammographic Breast

• Is ATOSSA THERAPEUTICS publicly traded?

  Yes. ATOSSA THERAPEUTICS is listed with ticker ATOS on NYSE per SEC EDGAR records linked on this profile.

• What drugs does ATOSSA THERAPEUTICS develop or market?

  We link 5 drug profile(s) where ATOSSA THERAPEUTICS is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/atossa-therapeutics-inc#company-drugs.

• What are the latest developments for ATOSSA THERAPEUTICS?

  In the last 12 months our linked public records show 10 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does ATOSSA THERAPEUTICS focus on?

  ATOSSA THERAPEUTICS focuses on Total Laryngectomy, Breast Cancer, Breast Cancer, Preneoplastic Conditions, BRCA based on our analysis of their pipeline programs and drug development activities.